Nektar Therapeutics (NASDAQ:NKTR)

12.46
BATS BZX Real-Time Price
As of 1:30pm ET
 +0.10 / +0.81%
Today’s Change
9.51
Today|||52-Week Range
17.53
-19.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues71.5M81.2M148.9M200.7M
 
 
 
 
 
Cost of Goods Sold6.9M15.9M24.2M15.6M
 
 
 
 
 
Depreciation And Amortization15.0M14.5M14.3M12.9M
 
 
 
 
 
 
Operating ExpensesGross Income49.6M50.8M110.4M172.2M
 
 
 
 
 
General Expenses170.8M190.3M219.2M188.7M
 
 
 
 
 
Research And Development126.8M148.7M178.7M147.7M
 
 
 
 
 
Total Operating Expenses192.7M220.7M257.8M217.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-121.2M-139.5M-108.8M-16.5M
 
 
 
 
 
Extraordinary Charge-2.7M-1.7M-11.3M--
 
 
 
 
Interest Expense On Debt10.2M33.5M40.8M38.8M
 
 
 
 
 
Other Expenses-1.0M983.0K392.0K814.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-133.0M-171.4M-159.8M-54.4M
 
 
 
 
 
Income Taxes-1.0M-406.0K-2.2M-512.0K
 
 
 
 
 
Net Income-134.0M-171.9M-162.0M-53.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS112.9M114.8M115.7M126.9M
 
 
 
 
 
Shares To Calculate EPS Diluted112.9M114.8M115.7M126.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.19-$1.50-$1.40-$0.42
 
 
 
 
 
EPS Diluted-$1.19-$1.50-$1.40-$0.42
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account